These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 2132409

  • 1. Increased plasma levels of IgA-IgG immune complexes and anti-F(ab')2 antibodies in patients with type 2 (non insulin-dependent) diabetes mellitus and microangiopathy.
    Casiglia D, Giardina E, Scarantino G, Triolo G.
    Diabetes Res; 1990 Dec; 15(4):195-200. PubMed ID: 2132409
    [Abstract] [Full Text] [Related]

  • 2. Increased serum levels of IgA1-IgG immune complexes and anti-F(ab')2 antibodies in patients with primary IgA nephropathy.
    Schena FP, Pastore A, Ludovico N, Sinico RA, Benuzzi S, Montinaro V.
    Clin Exp Immunol; 1989 Jul; 77(1):15-20. PubMed ID: 2788538
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Analysis of IgA1 and IgA2 subclass distribution in IgA- containing circulating immune complexes in patients with diabetes mellitus.
    Triolo G, Giardina E, Seddio G, Terrizzi C.
    Boll Ist Sieroter Milan; 1987 Jul; 66(2):116-9. PubMed ID: 3311077
    [Abstract] [Full Text] [Related]

  • 5. Stimulation of complement amplification by F(ab')(2)-containing immune complexes and naturally occurring anti-hinge antibodies, possible role in systemic inflammation.
    Lutz HU, Fumia S.
    Autoimmun Rev; 2008 Jun; 7(6):508-13. PubMed ID: 18558371
    [Abstract] [Full Text] [Related]

  • 6. Detection of anti-phospholipid (cardiolipin, phosphatidylserine) antibodies in the serum of patients with non insulin-dependent (type 2) diabetes mellitus and macroangiopathy. Coexistence of anti-platelet reactivity.
    Triolo G, Giardina E, Scarantino G, Seddio G, Bompiani G.
    Diabetes Res; 1989 Feb; 10(2):63-7. PubMed ID: 2743710
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Circulating immune complexes and B lymphocytes in diabetic patients with and without microangiopathy.
    Barañao RI, Tesone PA, Garberi JC, Mendelson MJ, Rumi LS.
    Acta Physiol Pharmacol Latinoam; 1985 Feb; 35(2):145-51. PubMed ID: 2938403
    [Abstract] [Full Text] [Related]

  • 9. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
    Turk Z, Sesto M, Skodlar J, Ferencak G, Turk N, Stavljenić-Rukavina A.
    Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
    [Abstract] [Full Text] [Related]

  • 10. Collagen binding activity in sera of patients with insulin-dependent (type 1) and non insulin-dependent (type 2) diabetes mellitus.
    Triolo G, Giardina E, Bompiani GD.
    J Clin Lab Immunol; 1988 Jul; 26(3):121-4. PubMed ID: 3230579
    [Abstract] [Full Text] [Related]

  • 11. The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy.
    Di Mario U, Ventriglia L, Iavicoli M, Guy K, Andreani D.
    Clin Exp Immunol; 1983 Jun; 52(3):575-80. PubMed ID: 6603299
    [Abstract] [Full Text] [Related]

  • 12. Circulating immune complexes, insulin antibodies, and deposits of immunoglobulins in the skin in diabetes.
    Josephsen PG, Permin H, Juhl F, Enk B, Svehag SE.
    Dan Med Bull; 1986 Jun; 33(3):171-4. PubMed ID: 3720367
    [Abstract] [Full Text] [Related]

  • 13. Human F(ab')2-containing immune complexes together with anti-hinge natural antibodies stimulate complement amplification in vitro and in vivo.
    Fumia S, Goede JS, Fischler M, Luginbühl A, Frick S, Fodor P, Lutz HU.
    Mol Immunol; 2008 May; 45(10):2951-61. PubMed ID: 18339427
    [Abstract] [Full Text] [Related]

  • 14. The significance of immunofluorescent immunoglobulin inclusions in polymorphonuclear leucocytes for the detection of circulating immune complexes.
    Kauffmann RH, de Rooy-Dijk HH, Klein F, Lafeber GJ, Cats A, van Es LA.
    Clin Exp Immunol; 1983 Oct; 54(1):203-12. PubMed ID: 6311469
    [Abstract] [Full Text] [Related]

  • 15. Molecular weights of IgA-circulating immune complexes (CIC) in patients with IgA nephropathy: application of HPLC and solid-phase anti-C3 Facb EIA.
    Eguchi K, Tomino Y, Yagame M, Nomoto Y, Sakai H, Suguki H, Hosoda K.
    Tokai J Exp Clin Med; 1988 Feb; 13(1):9-13. PubMed ID: 3068839
    [Abstract] [Full Text] [Related]

  • 16. [Illness stage and IgA-anti-Fab/F(ab')2 autoantibody activity in serum of patients with malignant head-neck tumors].
    Lorenz KJ, Süsal C, Opelz G, Maier H.
    Laryngorhinootologie; 1996 Dec; 75(12):764-8. PubMed ID: 9081283
    [Abstract] [Full Text] [Related]

  • 17. Anti-idiotypic antibodies to anti-PDC-E2 in primary biliary cirrhosis and normal subjects.
    Chen QY, Rowley MJ, Mackay IR.
    Hepatology; 1999 Mar; 29(3):624-31. PubMed ID: 10051459
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Normal human sera contain antibodies directed at Fab of IgA.
    Jackson S, Montgomery RI, Mestecky J, Czerkinsky C.
    J Immunol; 1987 Apr 01; 138(7):2244-8. PubMed ID: 3494062
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.